Inmune Bio Balance Sheet (2017-2026)

Reported Financials

Inmune Bio Quarterly Balance Sheet

Periods 35 quarters

Latest Jun 2026

Inmune Bio reported total assets of $26.84M and total liabilities of $6.48M for the quarter ended Jun 2026, down 28.8% year over year. This balance sheet covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	84.47M	74.81M	66.73M	61.21M	57.41M	52.15M	51.00M	47.83M	41.81M	35.85M	26.00M	31.07M	33.55M	20.92M	19.34M	33.37M	27.73M	24.75M	21.36M	18.41M
Cash & Current Investments	84.47M	74.81M	66.73M	61.21M	57.41M	52.15M	51.00M	47.83M	41.81M	35.85M	26.00M	31.07M	33.55M	20.92M	19.34M	33.37M	27.73M	24.75M	21.36M	18.41M
Receivables - NetNet Receivables										1.91M		3.14M	1.11M	1.18M	1.28M	1.60M	1.70M	4.28M	0.48M	4.41M
Receivables - OtherOther Receivables		0.30M	0.20M	0.20M	0.10M	0.36M				0.54M	0.56M	0.59M	0.55M	0.23M	0.13M	0.55M	0.76M	0.26M	0.29M	0.35M
Receivables										2.44M		3.73M	1.65M	1.41M	1.42M	2.15M	2.46M	4.54M	0.77M	4.77M
Prepaid Assets	1.30M	2.28M	4.67M	4.22M	4.60M	4.03M	3.63M	2.71M	1.53M	1.51M	1.11M	1.01M	0.86M	0.33M	0.21M	0.51M	0.47M	0.59M	0.69M	0.62M
Current Assets	90.93M	82.61M	77.06M	70.55M	66.66M	64.67M	56.88M	52.61M	45.61M	39.94M	29.82M	35.49M	35.85M	22.66M	20.96M	36.03M	30.67M	29.89M	22.82M	23.80M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)																0.71M	0.88M	0.95M	0.90M	1.26M
Intangibles	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M
Goodwill & Intangibles	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M
Other Non-Current Assets	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.13M	0.13M	0.13M	0.11M	0.08M	0.08M	0.08M	0.05M	0.57M	0.75M	0.59M	0.68M	0.54M
Non-Current Assets	16.74M	17.34M	17.29M	17.26M	17.14M	17.12M	17.10M	17.11M	17.09M	17.06M	17.01M	16.96M	16.93M	16.90M	16.84M	1.65M	2.69M	2.46M	3.00M	3.05M
Assets	107.67M	99.94M	94.35M	87.81M	83.80M	81.80M	73.98M	69.72M	62.70M	57.00M	46.83M	52.45M	52.78M	39.56M	37.80M	37.68M	33.36M	32.35M	25.82M	26.84M
Liabilities
Current Liabilities
Accounts Payables	4.22M	3.73M	2.55M	1.69M	3.46M	5.21M	2.08M	2.38M	3.67M	7.90M	9.29M	9.28M	10.59M	6.54M	7.20M	7.67M	6.88M	7.77M	4.66M	5.05M
Payables	4.22M	3.73M	2.55M	1.69M	3.46M	5.21M	2.08M	2.38M	3.67M	7.90M	9.29M	9.28M	10.59M	6.54M	7.20M	7.67M	6.88M	7.77M	4.66M	5.05M
Accumulated Expenses						0.01M	0.01M	0.01M	0.08M	0.04M	0.06M	0.14M
Other Accumulated Expenses	0.54M	0.47M	0.58M	0.48M	0.78M	0.62M	0.59M	0.56M	0.50M	0.49M	0.52M	0.52M	0.55M	0.52M	0.48M	0.51M
Short term Debt					2.50M	5.00M	7.50M	10.00M	10.00M	9.92M	7.46M	4.98M	2.49M
Total Current Liabilities	4.81M	4.36M	3.23M	2.29M	6.89M	10.92M	10.28M	13.05M	14.36M	18.46M	17.45M	15.05M	13.82M	7.22M	7.93M	8.59M	7.36M	8.42M	5.39M	5.89M
Non-Current Liabilities
Non-Current Debt	14.40M	14.46M	14.51M	14.57M	12.13M	9.70M	7.26M	4.82M	2.38M		7.50M	5.00M	2.50M
Non-Current Deffered Revenue
Preferred Stock Liabilities									0.80M	0.80M	0.80M	0.80M
Operating Leases	0.10M	0.28M	0.68M	0.65M	0.61M	0.53M	0.50M	0.46M	0.43M	0.40M	0.36M	0.32M	0.28M	0.24M	0.20M	0.23M	0.62M	0.41M	0.81M	0.59M
Other Non-Current Liabilities	0.24M					0.55M			0.80M
Total Non-Current Liabilities	19.17M	19.72M	18.71M			21.14M			17.96M
Total Liabilities	19.42M	19.72M	18.71M	17.88M	20.09M	21.69M	18.68M	19.07M	18.77M	19.66M	18.61M	16.17M	14.11M	7.46M	8.13M	8.82M	7.98M	8.83M	6.19M	6.48M
Shareholder's Equity
Total Debt	14.40M	14.46M	14.51M	14.57M	14.63M	14.70M	14.76M	14.82M	12.38M	9.92M	14.96M	9.98M	4.99M
Common Equity	88.25M	80.22M	75.64M	69.93M	63.71M	60.10M	55.30M	50.65M	43.93M	37.34M	28.22M	36.28M	38.67M	32.10M	29.67M	28.87M	25.38M	23.52M	19.62M	20.36M
Liabilities and Shareholders Equity	107.67M	99.94M	94.35M	87.81M	83.80M	81.80M	73.98M	69.72M	62.70M	57.00M	46.83M	52.45M	52.78M	39.56M	37.80M	37.68M	33.36M	32.35M	25.82M	26.84M
Retained Earnings	-54.04M	-63.72M	70.62M	-77.46M	85.18M	-91.01M	97.55M	-104.05M	112.61M	-121.02M	-132.05M	-141.79M	-153.89M	-163.10M	-172.84M	-197.30M	-203.77M	-209.04M	-214.44M	-215.72M
Preferred Shares

Inmune Bio Balance Sheet API

Pull Inmune Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INMB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "INMB", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=INMB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Inmune Bio INMB Balance Sheet (2017-2026)

Inmune Bio Quarterly Balance Sheet

Inmune Bio Balance Sheet API

Create an account

Sign In

Reset Password